Cynosure Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Sell
796
-214
-21% -$108K 0.05% 166
2025
Q4
$472K Sell
1,010
-82
-8% -$38.1K 0.05% 227
2025
Q3
$465K Hold
1,092
0.05% 222
2025
Q2
$418K Sell
1,092
-35
-3% -$12.6K 0.05% 253
2025
Q1
$389K Sell
1,127
-1,781
-61% -$573K 0.05% 166
2024
Q4
$873K Buy
2,908
+1,549
+114% +$541K 0.13% 85
2024
Q3
$552K Buy
1,359
+233
+21% +$85.3K 0.08% 141
2024
Q2
$362K Buy
1,126
+168
+18% +$54.6K 0.06% 314
2024
Q1
$320K Buy
+958
New +$293K 0.06% 243

Other funds holding HCA

Cynosure Group's HCA Position: Q1 2026 in Review

Cynosure Group reduced its HCA Healthcare (HCA) stake by 21% in Q1 2026, selling an estimated $108K and leaving 796 shares worth $377K. The position accounts for 0.05% of the portfolio, ranked #166.

Cynosure Group first reported a position in HCA in Q1 2024 and has held it in 9 quarters since. The position peaked at $873K in Q4 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Cynosure Group held 796 shares of HCA Healthcare worth $377K as of Q1 2026.
  • Cynosure Group sold 214 HCA Healthcare shares in Q1 2026, an estimated $108K.
  • HCA Healthcare made up 0.05% of Cynosure Group's portfolio in Q1 2026, its #166 holding.
  • Cynosure Group first reported a position in HCA Healthcare in Q1 2024 and has held it in 9 quarters since.
  • Cynosure Group's HCA Healthcare position peaked at $873K in Q4 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.